Last update 01 Nov 2024

Vidasym, Inc.

Private Company|
2002|
Illinois, United States
|
10-50
|
www.vidasym.com

Overview

Tags

Endocrinology and Metabolic Disease
Urogenital Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease2
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
Phosphates1
HSP70 heat-shock proteins1

Related

8
Drugs associated with Vidasym, Inc.
VS-505
Target
HSP70 heat-shock proteins
Mechanism
HSP70 heat-shock proteins inhibitors
Active Org.
Libang Biomedical (Jiangsu) Co., Ltd. [+2]
Originator Org.
Vidasym, Inc.
Active Indication
Chronic Kidney Diseases [+1]
Inactive Indication-
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
CK15
Target
VDR
Mechanism
VDR modulators
Active Org.
Xinkai Medicine and Chemical Intermediates (Shanghai) Co., Ltd. [+1]
Originator Org.
Vidasym, Inc.
Active Indication
Chronic Kidney Diseases [+2]
Inactive Indication
Kidney Failure, Chronic
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
VS-605
Target
Phosphates
Mechanism
Phosphates modulators
Active Org.
Vidasym, Inc.
Originator Org.
Vidasym, Inc.
Active Indication
Hyperphosphatemia
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Vidasym, Inc.
NCT03043482 / CompletedPhase 1
A Phase 1, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of VS 105 Following Oral Administration in Healthy and Hemodialysis Subjects
100 Clinical Results associated with Vidasym, Inc.
Login to view more data
0 Patents (Medical) associated with Vidasym, Inc.
Login to view more data
100 Deals associated with Vidasym, Inc.
Login to view more data
100 Translational Medicine associated with Vidasym, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
Phase 2 Clinical
Other
6
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
VS-505
 ( HSP70 heat-shock proteins )		Hyperphosphatemia
More
Phase 2
VS-605
 ( Phosphates )		Hyperphosphatemia
More
Preclinical
VS-320
 ( VDR )		Psoriasis
More
Discontinued
VS-110
 ( VDR )		Inflammatory Bowel Diseases
More
Discontinued
VS-501
Hyperphosphatemia
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free